USP–NF Compendial Notices

General Announcements are posted on USP's website to provide USP–NF users with general information about the USP–NF, Supplements, Pharmacopeial Forum (PF), or other USP standards-setting activities.

• <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures Revision Bulletin (posted 28–Jan–2013)
• <467> Frequently Asked Questions about <467> Residual Solvents
• <2232> Elemental Contaminants in Dietary Supplements (posted 27–Apr–2012)
• Admission Criteria and Safety Classification for Dietary Supplements Guideline Update (posted 18–Oct–2012)
• Call for Candidates: USP Dietary Supplements Safety Modeling Expert Panel (posted 26–Apr–2013)
• Complete Reagent Section No Longer Being Printed in Supplements to USP–NF (posted 01–Feb–2013)
• First Excipients Stakeholder Forum Scheduled for June (posted 22–Mar–2013)
• Errata Posting Schedule Revised (posted 14–Sep–2012)
• Errata Table Updated (posted 29–Mar–2013)
• General Notices and Requirements: Summary of Proposed Changes (posted 28–Dec–2012; updated 04–Feb–2013)
• Heparin Sodium Monograph Comment Period Extended (posted 30–Nov–2012)
• Nominations Being Accepted for the USP 2013 Awards Program (posted 26–Apr–2013)
• Online Enhancements to Help Users Access USP–NF New Official Text (posted 26–Oct–2012)
• Prescription/Nonprescription Stakeholder Forum Scheduled for June; Agenda Topics Sought (posted 31–Jan–2013; deadline 30–Apr–2013)
• Revision Bulletins to be Posted Bimonthly (posted 31–Aug–2012)
• Searchable Errata Database Launches (posted 30–Nov–2012)
• USP Monograph Modernization Initiative (posted 08–Feb–2011)
• USP Seeks Submission of Proposals for Monograph Modernization (posted 28–May–2010)
• USP Seeking Public Participation in Organic Impurities Survey (posted 26–Apr–2013)
• USP Seeking Public Participation in Residual Solvent Testing Survey (posted 26–Apr–2013)

USP provides Intent to Revise Announcements to notify users of official text that is under revision.

• <1> Injections and <788> Particulate Matter in Injections (posted 26–Aug–2011)
• <232> Elemental Impurities—Limits (posted 27–Apr–2012; updated 21–Nov–2012)
• <233> Elemental Impurities—Procedures (posted 27–Apr–2012; updated 21–Nov–2012)
• <659> Packaging and Storage Requirements (posted 27–Apr–2012; updated 21–Nov–2012 )
• <788> Particulate Matter in Injections and <1> Injections (posted 26–Aug–2011)
• Ampicillin (posted 01–Nov–2011)
• Atorvastatin Calcium (posted 25–Feb–2011)
• Benzalkonium Chloride and Benzalkonium Chloride Solution (posted 29–Dec–2011)
• Calcitonin Salmon Monographs (posted 28–Oct–2011)
• Colloidal Oatmeal (posted 27–Apr–2012)
• Copovidone (posted 09–Aug–2011)
• Esmolol Hydrochloride (28–Dec–2012)
• General Notices (posted 27–Apr–2012)
• Glycopyrrolate (posted 24–Feb–2012)
• Heparin Lock Flush Solution (posted 29–Jun–2012)
• Heparin Sodium Injection (posted 24–Feb–2012)
• High Fructose Corn Syrup (posted 26–Oct–2012)
• Levelbuterol Hydrochloride (posted 29–Jul–2011)
• Levelbuterol Inhalation Solution (posted 29–Jul–2011)
• Methylpyrrolidone (posted 01–Aug–2012)
• Mirtazapine Tablets (posted 29–Jul–2011)
• Modafinil (posted 19–Jun–2009)
• Olanzapine Tablets (posted 27–May–2011)
• Orlistat (posted 22–Mar–2013)
• Sertraline Tablets (posted 26–Aug–2011)
• Simethicone Emulsion (posted 27–Apr–2012)
• Tramadol Hydrochloride (posted 29–Jun–2012)
• Travoprost Ophthalmic Solution (posted 25–Feb–2011)
• Valacyclovir Hydrochloride (posted 30–Jun–2011)
• Vasopressin (posted 31–Mar–2011)

USP–NF Redesigned Monographs

The downloadable Excel file below lists titles of monographs appearing in an official publication (USP–NF or Supplement) in the redesigned format. Monographs are redesigned either through USP’s revision process in the Pharmacopeial Forum (PF), accelerated revision, or as part of USP’s ongoing redesign process. The list can be sorted by monograph type, Expert Committee designation, or publication vehicle in which the monograph initially appeared in the redesigned format. This list is updated with the publication of each new USP–NF and Supplement. Currently, some drug substance monographs do not include the chemical structure of the article or may incorrectly include a structure in a dosage form monograph. As part of the redesign effort, the chemical structure of the article is being deleted or added to these monographs as an editorial change.

For questions regarding the redesign process, email redesign@usp.org.

• List of monographs appearing in redesigned format as of USP 36–NF 31 1S (posted 01–Feb–2013)

Publications Corrections

• PF 39(1) Posting (posted 20–Mar–2013)
• USP 36–NF 31 Flash Drive Information (posted 11–Mar–2013)
• Errata Tables Corrected (posted 22–Feb–2013)
• General Chapter <911> Viscosity Reference Corrections in Monographs (posted 31–May–2012)
• Change to General Chapters Reference to Preservation, Packaging, Storage and Labeling Section of General Notices (posted 18–May–2012)

Retired Compendial Notices